Rutherford, Australia

Peter John Kieran

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Nelson's Bay, AU (2011)
  • Rutherford, AU (2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Peter John Kieran

Introduction

Peter John Kieran is a notable inventor based in Rutherford, Australia. He has made significant contributions to the field of veterinary medicine, particularly in anaesthetic compositions. With a total of 2 patents to his name, Kieran's work has had a positive impact on the treatment of animals.

Latest Patents

Kieran's latest patents focus on a stable anaesthetic composition that is particularly suitable for use in cats and dogs. The composition comprises an aqueous solution of an anaesthetically effective amount of water-soluble cyclodextrin or a cyclodextrin derivative complex of alfaxalone. Additionally, it includes a buffer, excluding phosphate buffer pH 7.0, 0.1 M, mixed as defined in the British Pharmacopoeia 1998. The pH of the solution is maintained between 6.0 and 8.0, ensuring its effectiveness and safety for veterinary use.

Career Highlights

Kieran has been associated with Jurox Pty Ltd, a company known for its commitment to veterinary pharmaceuticals. His work at Jurox has allowed him to develop innovative solutions that enhance the quality of care for pets. His contributions have been instrumental in advancing veterinary anaesthesia practices.

Collaborations

Throughout his career, Kieran has collaborated with talented individuals such as Kai Kin Lau and Barry Edward Patten. These collaborations have fostered an environment of innovation and have led to the development of effective veterinary solutions.

Conclusion

Peter John Kieran's contributions to veterinary medicine through his innovative anaesthetic compositions demonstrate his commitment to improving animal care. His work continues to influence the field positively, making him a significant figure in veterinary pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…